Author Details

Radecka, Barbara

  • Vol 63, No 2 (2013) - Original article
    Retrospective analysis of eff ectiveness and toleration of treatment with platinum derivative and pemetrexed in patients with advanced (stage IIIB and IV) non-small non-squamous cell lung cancer in a few oncology centers
    Abstract  PDF (Polish)
  • Vol 63, No 2 (2013) - Reports
    Polacy w San Antonio — polskie akcenty podczas San Antonio Breast Cancer Symposium, SABCS
    Details  PDF (Polish)
  • Vol 64, No 2 (2014) - Original article
    Prognostic significance of dose intensity and haematological toxicity in breast cancer patients administered with adjuvant CMF chemotherapy
    Abstract  PDF (Polish)  HTML (Polish)
  • Vol 66, No 6 (2016) - Review article
    Trastuzumab as adjuvant treatment for early stage HER2-positive breast cancer — a 10 year history
    Abstract  PDF
  • Vol 66, No 6 (2016) - Short review
    Should oncologists be responsible for monitoring post-treatment follow-up in cancer patients?
    Abstract  PDF
  • Vol 67, No 2 (2017) - Original article
    Adjuvant chemotherapy for early-stage breast cancer patients — daily clinical practice in selected cancer centres in Poland
    Abstract  PDF
  • Vol 70, No 2 (2020) - COVID-19
    Leczenie systemowe pacjentów z rozpoznaniem choroby nowotworowej w kontekście pandemii SARS-CoV-2 – stanowisko Polskiego Towarzystwa Onkologii Klinicznej
    Details  PDF (Polish)
  • Vol 71, No 5 (2021) - Invited editorial
    Pregnancy-associated breast cancer as a screening and diagnostic challenge
    Details  PDF

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl